World's Best Scientists 2026 revealed!
Michio Imamura

Michio Imamura

D-Index & Metrics

Microbiology

D-Index
57
Citations
9938
World Ranking
3616
National Ranking
142

Michio Imamura publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Michio Imamura sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 294 publications — 76th percentile

76% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Michio Imamura D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Michio Imamura sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 57 D-Index — 36th percentile

36% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Michio Imamura is affiliated with Hiroshima University in Japan and has contributed extensively to the field of medicine, with a primary focus on hepatology and related subfields. Their research encompasses a broad spectrum within liver diseases, particularly hepatitis and hepatocellular carcinoma.

Imamura's publication record includes significant works related to liver disease diagnosis and treatment, hepatitis C virus research, hepatocellular carcinoma treatment and prognosis, and hepatitis B virus studies. Their contributions have been published in notable venues such as Research Square, Journal of Hepatology, Oncology, Cancers, and Clinical Journal of Gastroenterology.

Key recent papers authored or co-authored by Imamura include the following:

  • Efficacy and Safety of Bepirovirsen in Chronic Hepatitis B Infection (2022, New England Journal of Medicine)
  • Efficacy and Safety of Lenvatinib-Transcatheter Arterial Chemoembolization Sequential Therapy for Patients with Intermediate-Stage Hepatocellular Carcinoma (2021, Oncology)
  • Tumor Fibroblast Growth Factor Receptor 4 Level Predicts the Efficacy of Lenvatinib in Patients With Advanced Hepatocellular Carcinoma (2020, Clinical and Translational Gastroenterology)
  • Road to elimination of HCV: Clinical challenges in HCV management (2021, Liver International)
  • Phase IIa, randomised, double-blind study of GSK3389404 in patients with chronic hepatitis B on stable nucleos(t)ide therapy (2022, Journal of Hepatology)

Their frequent collaborators include Hiroshi Aikata, Takashi Nakahara, Tomokazu Kawaoka, Eisuke Murakami, and Kazuaki Chayama, each having co-authored multiple works alongside Imamura.

Imamura's main fields of study within medicine include:

  • Hepatology
  • Epidemiology
  • Oncology
  • Surgery
  • Pathology and Forensic Medicine

The scientist's research topics cover:

  • Liver Disease Diagnosis and Treatment
  • Hepatitis C virus research
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Hepatitis B Virus Studies
  • Liver Disease and Transplantation
  • Cancer Mechanisms and Therapy
  • Cancer Immunotherapy and Biomarkers

Best Publications

  • Identification of the Niemann-Pick C1–like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor

    Bruno Sainz;Naina Barretto;Danyelle N Martin;Nobuhiko Hiraga

  • HCV-Induced Epigenetic Changes Associated With Liver Cancer Risk Persist After Sustained Virologic Response.

    Nourdine Hamdane;Nourdine Hamdane;Frank Jühling;Frank Jühling;Emilie Crouchet;Emilie Crouchet;Houssein El Saghire;Houssein El Saghire

  • Suppression of macrophage infiltration inhibits activation of hepatic stellate cells and liver fibrogenesis in rats.

    Michio Imamura;Michio Imamura;Tadashi Ogawa;Yasuyuki Sasaguri;Kazuaki Chayama

  • G to A hypermutation of hepatitis B virus

    Chiemi Noguchi;Hiromi Ishino;Masataka Tsuge;Yoshifumi Fujimoto

  • Balloon-occluded retrograde transvenous obliteration of gastric fundal varices with hemorrhage.

    Mikiya Kitamoto;Michio Imamura;Koji Kamada;Hiroshi Aikata

  • Infection of human hepatocyte chimeric mouse with genetically engineered hepatitis B virus.

    Masataka Tsuge;Nobuhiko Hiraga;Hideki Takaishi;Chiemi Noguchi

  • Common variation of IL28 affects gamma-GTP levels and inflammation of the liver in chronically infected hepatitis C virus patients

    Hiromi Abe;Hidenori Ochi;Toshiro Maekawa;C. Nelson Hayes

  • Efficacy and safety of edoxaban for treatment of portal vein thrombosis following danaparoid sodium in patients with liver cirrhosis.

    Yuko Nagaoki;Hiroshi Aikata;Kana Daijyo;Yuji Teraoka

  • Repurposing of the antihistamine chlorcyclizine and related compounds for treatment of hepatitis C virus infection

    Shanshan He;Billy Lin;Virginia Chu;Zongyi Hu

  • Genetics of IL28B and HCV—response to infection and treatment

    C. Nelson Hayes;Michio Imamura;Hiroshi Aikata;Kazuaki Chayama

  • The long-term outcome of patients with bleeding gastric varices after balloon-occluded retrograde transvenous obliteration

    Nobuhiko Hiraga;Hiroshi Aikata;Shintaro Takaki;Hideaki Kodama

  • HCV substitutions and IL28B polymorphisms on outcome of peg-interferon plus ribavirin combination therapy

    C Nelson Hayes;Mariko Kobayashi;Norio Akuta;Fumitaka Suzuki

  • HBx protein is indispensable for development of viraemia in human hepatocyte chimeric mice

    Masataka Tsuge;Nobuhiko Hiraga;Rie Akiyama;Sachi Tanaka

  • IL28 variation affects expression of interferon stimulated genes and peg-interferon and ribavirin therapy

    Hiromi Abe;C. Nelson Hayes;Hidenori Ochi;Toshiro Maekawa

  • Adoptive immunotherapy with liver allograft–derived lymphocytes induces anti-HCV activity after liver transplantation in humans and humanized mice

    Masahiro Ohira;Kohei Ishiyama;Yuka Tanaka;Marlen Doskali

  • Recent trend of clinical features in patients with hepatocellular carcinoma

    Yuko Nagaoki;Hideyuki Hyogo;Hiroshi Aikata;Mio Tanaka

  • Amphipathic DNA Polymers Inhibit Hepatitis C Virus Infection by Blocking Viral Entry

    Takuya Matsumura;Zongyi Hu;Takanobu Kato;Marlene Dreux

  • A novel TK-NOG based humanized mouse model for the study of HBV and HCV infections.

    Keiichi Kosaka;Nobuhiko Hiraga;Nobuhiko Hiraga;Michio Imamura;Michio Imamura;Satoshi Yoshimi;Satoshi Yoshimi

  • Predictive value of the IL28B polymorphism on the effect of interferon therapy in chronic hepatitis C patients with genotypes 2a and 2b

    Tomokazu Kawaoka;C. Nelson Hayes;Waka Ohishi;Waka Ohishi;Hidenori Ochi

  • Involvement of Porphyromonas gingivalis in the progression of non-alcoholic fatty liver disease.

    Takashi Nakahara;Takashi Nakahara;Hideyuki Hyogo;Atsushi Ono;Atsushi Ono;Yuko Nagaoki;Yuko Nagaoki

  • Rapid emergence of telaprevir resistant hepatitis C virus strain from wildtype clone in vivo

    Nobuhiko Hiraga;Michio Imamura;Hiromi Abe;C. Nelson Hayes

Frequent Co-Authors

Kazuaki Chayama
Kazuaki Chayama Hiroshima University
Katsutoshi Yoshizato
Katsutoshi Yoshizato Osaka Metropolitan University
Hiromitsu Kumada
Hiromitsu Kumada Fukuoka University
Fumitaka Suzuki
Fumitaka Suzuki Toranomon Hospital
Takaji Wakita
Takaji Wakita National Institute of Infectious Diseases
Yusuke Nakamura
Yusuke Nakamura National Institutes of Biomedical Innovation, Health and Nutrition
Shinji Tanaka
Shinji Tanaka Hiroshima University
Naoyuki Kamatani
Naoyuki Kamatani StaGen (Japan)
Tatsuhiko Tsunoda
Tatsuhiko Tsunoda University of Tokyo

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in microbiology, exploring related online degrees can open diverse career opportunities. Many professionals choose to enhance their skills by enrolling in accredited online mph programs easy to get into. These programs provide a public health perspective that complements microbiology expertise, preparing graduates for careers in epidemiology and health policy.

Career paths connected to microbiology also include specialized healthcare roles. For instance, becoming a child life specialist blends knowledge of health sciences with emotional support for young patients. Understanding how much does a child life specialist make can help guide students considering this vocation.

Furthermore, certain online degrees offer accessible options to non-traditional students, including those with prior convictions. Resources that highlight the college degrees for felons can provide valuable information on programs that support rehabilitation and career growth in the sciences.

For those interested in healthcare innovation, the path to becoming a functional medicine nurse practitioner merges clinical practice with an integrative approach to health. Learning how to become a functional medicine nurse practitioner offers insight into specialized training that complements microbiology backgrounds.

Best Scientists Citing Michio Imamura

Trending Scientists

Recently Published Articles